Compare Saranacentral Bajatama Tbk (BAJA) vs Merck Tbk. (MERK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Saranacentral Bajatama Tbk vs Merck Tbk. — how do they compare? Saranacentral Bajatama Tbk trades at Rp161 (market cap 288B, 1.21M 24h volume), while Merck Tbk. trades at Rp3,740 (market cap 1.68T, 22.8K 24h volume). The key difference: Merck Tbk. is far larger — about 5.8× Saranacentral Bajatama Tbk's market cap, and Saranacentral Bajatama Tbk is more actively traded (1.21M versus 22.8K). Which is the better fit depends on your goals.
| BAJA | MERK | |
|---|---|---|
Market Cap | 288B | 1.68T |
Volume | 1.21M | 22.8K |
Lot | 12.09K | 228 |
Turnover | 193.62M | 82.9M |
Average Price | 160.18 | 3,636.14 |
Value | 193.62M | 82.9M |
Indicative Equilibrium Price | 161 | 3,520 |
Indicative Equilibrium Volume | 4 | 60 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Saranacentral Bajatama Tbk
PT. Saranacentral Bajatama (SCB), established in 1996, is belonging to Sarana Steel Group, which was set up in 1970 and has built up its strong reputation in the worldwide steel industry. In order to provide competitive Hot-Dip Galvanized Steel Sheet/Coil to the customers, SCB take advantage of more advanced NOF (Non-Oxidation Furnace) System for production process, by which SCB differentiate itself from other competitors that use conventional processing system.
Read more on BAJA →About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →
